In addition, plasma levels of BDNF are reduced in AD patients or patients with cognitive impairment (Gezen-Ak et al., 2013; Nasrolahi et al., 2022; Shimada et al., 2014; Yasutake et al., 2006). Here, BDNF is linked to Alzheimer disease.